UAMC-3203 hydrochloride is primarily investigated for its potential therapeutic applications in medical research, particularly in the field of oncology. It is studied for its ability to inhibit specific enzymes or pathways involved in cancer cell proliferation and survival. Researchers are exploring its efficacy in targeting certain types of tumors, with a focus on understanding its mechanism of action and optimizing its use in combination therapies. Additionally, it is being evaluated for its pharmacokinetic properties to determine its suitability as a drug candidate. Its application extends to preclinical studies, where it is used to assess safety, dosage, and potential side effects in animal models.